Amany Zekry

4.7k total citations · 1 hit paper
68 papers, 2.1k citations indexed

About

Amany Zekry is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Amany Zekry has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 44 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Amany Zekry's work include Hepatitis C virus research (38 papers), Liver Disease Diagnosis and Treatment (37 papers) and Hepatitis B Virus Studies (15 papers). Amany Zekry is often cited by papers focused on Hepatitis C virus research (38 papers), Liver Disease Diagnosis and Treatment (37 papers) and Hepatitis B Virus Studies (15 papers). Amany Zekry collaborates with scholars based in Australia, United States and United Kingdom. Amany Zekry's co-authors include Geoffrey W. McCaughan, Jason Behary, Nicholas Shackel, G. Alex Bishop, Josette Eris, Peter H. McGuinness, Jian Yin, Martin Weltman, Andrew R. Lloyd and Emad El‐Omar and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Amany Zekry

65 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

2021 331 citations Jason Behary, Nadia Amorim et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amany Zekry Australia	25	1.2k	930	500	212	210	68	2.1k
Masahiko Kaito Japan	29	1.5k 1.2×	1.3k 1.4×	539 1.1×	199 0.9×	242 1.2×	85	2.8k
Yueyong Zhu China	26	1.4k 1.1×	749 0.8×	384 0.8×	296 1.4×	229 1.1×	111	2.3k
Yoshihiko Yano Japan	23	1.0k 0.8×	897 1.0×	204 0.4×	151 0.7×	125 0.6×	152	1.7k
Woo Jin Chung South Korea	26	958 0.8×	895 1.0×	328 0.7×	609 2.9×	382 1.8×	113	2.4k
Ayano Inui Japan	26	1.1k 0.9×	977 1.1×	207 0.4×	423 2.0×	201 1.0×	163	2.0k
Annagiulia Gramenzi Italy	29	1.4k 1.2×	1.6k 1.7×	289 0.6×	478 2.3×	373 1.8×	86	2.7k
Sung Won Cho South Korea	28	1.4k 1.1×	1.3k 1.4×	422 0.8×	542 2.6×	233 1.1×	143	2.8k
Christopher Koh United States	31	2.2k 1.8×	1.8k 2.0×	326 0.7×	367 1.7×	134 0.6×	138	3.3k
Wolfgang H. Caselmann Germany	29	1.0k 0.9×	912 1.0×	711 1.4×	217 1.0×	419 2.0×	77	2.3k
Nurdan Tözün Türkiye	25	753 0.6×	576 0.6×	183 0.4×	544 2.6×	179 0.9×	106	1.8k

Countries citing papers authored by Amany Zekry

Since Specialization

Citations

This map shows the geographic impact of Amany Zekry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany Zekry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany Zekry more than expected).

Fields of papers citing papers by Amany Zekry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amany Zekry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany Zekry. The network helps show where Amany Zekry may publish in the future.

Co-authorship network of co-authors of Amany Zekry

This figure shows the co-authorship network connecting the top 25 collaborators of Amany Zekry. A scholar is included among the top collaborators of Amany Zekry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amany Zekry. Amany Zekry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moridani, Mohammad Karimi, Jason Behary, Azadeh Safarchi, et al.. (2025). Benchmarking ensemble machine learning algorithms for multi-class, multi-omics data integration in clinical outcome prediction. Briefings in Bioinformatics. 26(2). 7 indexed citations

Caldwell, Kim A., et al.. (2024). Exploring Misconceptions of Palliative Care Among Patients With Hepatocellular Carcinoma: A Pilot Study. American Journal of Hospice and Palliative Medicine®. 42(5). 467–476.

Zandavi, Seid Miad, Thomas Goodwin, Ammar Majeed, et al.. (2024). AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors. Liver International. 44(10). 2724–2737. 7 indexed citations

Clark, Paul J., Patricia C. Valery, Simone I. Strasser, et al.. (2023). Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. Journal of Gastroenterology and Hepatology. 39(3). 568–575. 2 indexed citations

Shen, Sj, Saroj Khatiwada, Anita Raposo, et al.. (2023). IDDF2023-ABS-0223 Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC. A14.1–A14. 2 indexed citations

Kochovska, Slavica, et al.. (2023). Barriers to palliative care in hepatocellular carcinoma: A review of the literature. Journal of Gastroenterology and Hepatology. 38(7). 1047–1055. 7 indexed citations

Khatiwada, Saroj, et al.. (2023). Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes. 15(2). 2240031–2240031. 50 indexed citations

Amorim, Nadia, Emily McGovern, Anita Raposo, et al.. (2022). Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination. Frontiers in Medicine. 9. 770017–770017. 24 indexed citations

Behary, Jason, et al.. (2021). Microbiota and liver disease: year in review. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Behary, Jason, Anita Raposo, Nadia Amorim, et al.. (2021). Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model. BMC Microbiology. 21(1). 113–113. 22 indexed citations

11.

Behary, Jason, Nadia Amorim, Xiaotao Jiang, et al.. (2021). Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nature Communications. 12(1). 187–187. 331 indexed citations breakdown →

12.

Williams, Kathryn, Emilia Prakoso, Anne-Sophie Veillard, et al.. (2015). Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Research and Clinical Practice. 108(3). 466–472. 28 indexed citations

13.

Palmer, Clovis S., David Simar, Barbara Cameron, et al.. (2014). Characterisation of the cytokine milieu associated with the up‐regulation of IL‐6 and suppressor of cytokine 3 in chronic hepatitis C treatment non‐responders. Liver International. 35(2). 463–472. 5 indexed citations

14.

Keoshkerian, Elizabeth, Karla J. Helbig, Michael R. Beard, et al.. (2011). A novel assay for detection of hepatitis C virus-specific effector CD4+ T cells via co-expression of CD25 and CD134. Journal of Immunological Methods. 375(1-2). 148–158. 26 indexed citations

15.

Zekry, Amany, et al.. (2009). Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes. Journal of Gastroenterology and Hepatology. 24(6). 998–1001. 8 indexed citations

16.

Dev, Anouk, William T. Symonds, Keyur Patel, et al.. (2008). Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase. Journal of Viral Hepatitis. 15(8). 571–577. 11 indexed citations

17.

Dev, Anouk, Teresa L. Kauf, Amany Zekry, et al.. (2008). Factors influencing the participation of gastroenterologists and hepatologists in clinical research. BMC Health Services Research. 8(1). 208–208. 20 indexed citations

18.

White, Ian R., Keyur Patel, William T. Symonds, et al.. (2007). Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. Journal of Translational Medicine. 5(1). 33–33. 43 indexed citations

19.

Patel, Keyur, Amany Zekry, & John G. McHutchison. (2005). Steatosis and Chronic Hepatitis C Virus Infection: Mechanisms and Significance. Clinics in Liver Disease. 9(3). 399–410. 24 indexed citations

20.

Zekry, Amany, Stephen J. Williams, David Hunt, et al.. (2000). Palliation of hilar biliary obstruction from colorectal metastases by endoscopic stent insertion. Gastrointestinal Endoscopy. 51(4). 412–417. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact